Zobrazeno 1 - 10
of 46
pro vyhledávání: '"Florence Herr"'
Autor:
Manon Dekeyser, Jean-Luc Taupin, Michelle Elias, Philippe Ichaï, Florence Herr, Marc Boudon, Melanie Brunel, Antonio Sa cunha, Audrey Coilly, Faouzi Saliba, Antoine Durrbach
Publikováno v:
Frontiers in Medicine, Vol 9 (2022)
BackgroundAcute rejection rate is low after simultaneous liver–kidney transplantation (SLKT), leading some groups to minimize immunosuppressive (IS) regimens. However, the impact of preformed (pDSA) or de novo donor-specific antibodies (dnDSA) on t
Externí odkaz:
https://doaj.org/article/dd6ca8d0745b497d9984d7c6e7ae0d0e
Autor:
Florence Herr, Manon Dekeyser, Jerome Le Pavec, Christophe Desterke, Andrada-Silvana Chiron, Karen Bargiel, Olaf Mercier, Amelia Vernochet, Elie Fadel, Antoine Durrbach
Publikováno v:
Pharmaceutics, Vol 15, Iss 4, p 1299 (2023)
Calcineurin inhibitors have improved graft survival in solid-organ transplantation but their use is limited by toxicity, requiring a switch to another immunosuppressor in some cases. Belatacept is one option that has been shown to improve graft and p
Externí odkaz:
https://doaj.org/article/c7cba020b1064bcab771e8197fd3e721
Autor:
Xiaomeng Zhang, Florence Herr, Amelia Vernochet, Hans K. Lorenzo, Séverine Beaudreuil, Antoine Dürrbach
Publikováno v:
Frontiers in Immunology, Vol 11 (2020)
Introduction: Focal and segmental glomerulosclerosis (FSGS) is a frequent form of glomerulonephritis that may be caused by a soluble permeability factor and regulated by the immune system. We previously described a soluble form of calcium/calmodulin-
Externí odkaz:
https://doaj.org/article/f7a4703d71944e999b0b425b0cab34c8
Autor:
Severine Beaudreuil, Xiaomeng Zhang, Florence Herr, Francis Harper, Jean Jacques Candelier, Ye Fan, Hilal Yeter, Caroline Dudreuilh, Lola Lecru, Aime Vazquez, Bernard Charpentier, Hans K Lorenzo, Antoine Durrbach
Publikováno v:
PLoS ONE, Vol 14, Iss 7, p e0219353 (2019)
IntroductionFocal and Segmental GlomeruloSclerosis (FSGS) can cause nephrotic syndrome with a risk of progression to end-stage renal disease. The idiopathic form has a high rate of recurrence after transplantation, suggesting the presence of a system
Externí odkaz:
https://doaj.org/article/571ac2ad55da488bac30158086a557db
Autor:
Karen Bargiel, Florence Herr, Bernard Vanhove, Christophe Desterke, Manon Dekeyser, Antoine Durrbach, Fan Ye, Radu Vadanici, Amelia Vernochet
Publikováno v:
American Journal of Transplantation. 22:489-503
Belatacept was developed to replace calcineurin inhibitors in kidney transplantation. Its use is associated with better kidney transplant function, a lower incidence of anti-donor antibodies and higher graft survival. However, it is also associated w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cf5fea1d2e78d18eba0df251bb6918bb
https://doi.org/10.1111/ajt.16811
https://doi.org/10.1111/ajt.16811
Autor:
Nathalie Roders, Florence Herr, Gorbatchev Ambroise, Olivier Thaunat, Alain Portier, Aimé Vazquez, Antoine Durrbach
Publikováno v:
Frontiers in Immunology, Vol 9 (2018)
B cells play a major role in the antibody-mediated rejection (AMR) of solid organ transplants, a major public health concern. The germinal center (GC) is involved in the generation of donor-specific antibody-producing plasma cells and memory B cells,
Externí odkaz:
https://doaj.org/article/77b0c18c05c9435b801c04b7b4e02a09
Autor:
Manon Dekeyser, Marie-Ghislaine de Goër de Herve, Houria Hendel-chavez, Emmanuelle Boutin, Florence Herr, Romain Lhotte, Jean-Luc Taupin, Yassine Taoufik, Antoine Durrbach
BK-virus-associated nephropathy (BKvAN) is a major complication in kidney transplant recipients, associated with a higher level of BK-virus (BKv) replication and leading to poor graft survival. In a large cohort of kidney transplant recipients with v
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ce1c3fb3d172f9cf5ad3f5bb79c6e527
https://doi.org/10.21203/rs.3.rs-1650939/v1
https://doi.org/10.21203/rs.3.rs-1650939/v1
Publikováno v:
Drugs. 76:1589-1600
Long-term survival of solid allografts depends on both immunosuppressive efficacy and reducing the side effects associated with these therapies. Immunotherapies developed over the past 15 years to prevent organ rejection have greatly improved cardiov
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3b5833e7ff08bd45071a5c93253c754f
https://doi.org/10.1007/s40265-016-0656-2
https://doi.org/10.1007/s40265-016-0656-2
Publikováno v:
Current Transplantation Reports. 3:348-357
The properties of mesenchymal stem cells (MSCs) have become better known over the past decade and show potentially attractive new capabilities in solid-organ transplantation. After systemic administration, MSCs migrate to the damaged tissues, engraft
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::af76e665ed1949901f73fa9baa7ec909
https://doi.org/10.1007/s40472-016-0120-y
https://doi.org/10.1007/s40472-016-0120-y
Publikováno v:
Stem cells and development. 28(1)
Mesenchymal stem cells (MSCs) are powerful immunomodulators that regulate the diverse functions of immune cells involved in allogeneic reactions, such as T cells and natural killer (NK) cells, through cell-cell contact or secreted factors. Exosomes s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::71708fde9f49078258aadaa5d28927ab
https://pubmed.ncbi.nlm.nih.gov/30328799
https://pubmed.ncbi.nlm.nih.gov/30328799